There’s been some promising research for Transcranial Magnetic Stimulation (TMS), but can it be used for treatment-resistant depression in children and adolescents? Here’s a summary of the pros and cons presented in this 2019 article in The Carlat Child Psychiatry Report. Pros:It seems to work. An open-label trial of TMS for...
Pavan Madan, MD.Dr. Madan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Repetitive behaviors are part and parcel of the everyday challenges in autism spectrum disorders. The apparent similarly of these behaviors with obsessive compulsive disorders begs for trials of SSRIs such as fluoxetine (Prozac). But does this strategy work with any clear reliability? This research reviews addresses that question, with interesting results that impact everyday practice.
Kristen Gardner, PharmD.Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
More is not necessarily better in psychopharmacology. Some medications have plateau effect, while others follow a “U-shaped curve,” causing more problems as the dose goes too high. This metaanalysis looked at 77 dose-response trials with antidepressants to quantify their optimal therapeutic window.
For years, autism care has centered on one model, but that’s changing. The American Academy of Child and Adolescent Psychiatry just redefined what evidence-based care really...